TITLE

Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma?

AUTHOR(S)
Gi-Hong Choi; Dong-Hyun Kim; Chang-Moo Kang; Kyung-Sik Kim; Jin-Sub Choi; Woo-Jung Lee; Byong-Ro Kim
PUB. DATE
December 2007
SOURCE
World Journal of Surgery;Dec2007, Vol. 31 Issue 12, p2370
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Whether preoperative transarterial chemoembolization (TACE) has the therapeutic benefits in patients with resectable hepatocellular carcinoma (HCC) remains uncertain. We retrospectively investigated the influence of preoperative TACE on both disease-free survival and the pattern of recurrence after curative resection. From March 1998 to January 2005, a series of 273 patients who underwent curative resection for HCC were reviewed. Altogether, 120 patients underwent preoperative TACE, and 153 patients did not. We compared disease-free survival and the recurrence patterns between TACE and non-TACE groups, as well as between subgroups, stratified with regard to initial tumor size (≤3 cm, 3–5 cm, >5 cm) and pathologic tumor stage (stage I-II and stage III-IVa). We also compared disease-free survival and the pattern of recurrence among the three groups: complete necrosis, incomplete necrosis, non-TACE groups. The 1-, 3-, and 5-year disease-free survival rates were 76.0%, 57.7%, and 51.3%, respectively, in the TACE group and 70.9%, 53.8%, and 46.8%, respectively, in the non-TACE group. No significant difference was observed in disease-free survival or the pattern of recurrence between the TACE and non-TACE groups. Further analysis of disease-free survival and the pattern of recurrence between subgroups according to initial tumor size and tumor stage showed no significant differences. Complete necrosis of tumor was recognized in only 33 patients of the TACE group ( p = 0.001). Among the three complete necrosis, incomplete necrosis, and non-TACE groups, no significant difference was observed in disease-free survival or the pattern of recurrence. Preoperative TACE did not significantly improve the disease-free survival or the pattern of recurrence after curative resection of HCC. Even though this study is a retrospective analysis, preoperative TACE cannot be recommended as a routine procedure before hepatectomy for a resectable HCC.
ACCESSION #
27734058

 

Related Articles

  • Differentiating the impact of anatomic and non-anatomic liver resection on early recurrence in patients with Hepatocellular Carcinoma. Eltawil, Karim M.; Kidd, Mark; Giovinazzo, Francesco; Helmy, Ahmed H.; Salem, Ronald R. // World Journal of Surgical Oncology;2010, Vol. 8, p43 

    Background: For Hepatocellular Carcinoma (HCC) treated with hepatectomy, the extent of the resection margin remains controversial and data available on its effect on early tumor recurrence are very few and contradictory. The purpose of this study was to compare the impact of the type of...

  • Prognostic factors affecting survival and recurrence after hepatic resection for hepatocellular carcinoma in cirrhotic liver. Abdel-Wahab, Mohamed; El-Husseiny, Tarek Salah; Hanafy, Ehab E. I.; Shobary, Mohamed E. I.; Hamdy, Emad // Langenbeck's Archives of Surgery;Aug2010, Vol. 395 Issue 6, p625 

    Hepatic resections for hepatocellular carcinoma (HCC) in cirrhotic liver are characterized by early recurrence and poor survival. In this study, we analyzed several factors affecting both survival and recurrence after hepatic resection. From October 1995 to April 2007, 550 patients underwent...

  • Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma. Hakamada, Kenichi; Kimura, Norihisa; Miura, Takuya; Morohashi, Hajime; Ishido, Keinosuke; Nara, Masaki; Toyoki, Yoshikazu; Narumi, Shunji; Sasaki, Mutsuo; Jovanovic, Dusan M. // World Journal of Gastroenterology;3/7/2008, Vol. 14 Issue 9, p1370 

    AIM: To clarify the effect of a high des-gamma-carboxy prothrombin (DCP) level on the invasiveness and prognosis of small hepatocellular carcinoma. METHODS: Among 142 consecutive patients with known DCP levels, who underwent hepatectomy because of hepatocellular carcinoma, 85 patients met the...

  • Parenchyma-preserving hepatic resection for colorectal liver metastases. Heesen, Maximilian; Schuld, Jochen; Sperling, Jens; Grünhage, Frank; Lammert, Frank; Richter, Sven; Schilling, Martin; Kollmar, Otto // Langenbeck's Archives of Surgery;Mar2012, Vol. 397 Issue 3, p383 

    Background: Hepatic resection of colorectal liver metastases is the only curative treatment option. As clinical and experimental data indicate that the extent of liver resection correlates with growth of residual metastases, the present study analyzes the potential benefit of a...

  • Ultrasound-guided microwave coagulation assists anatomical hepatic resection. Imura, Satoru; Shimada, Mitsuo; Utsunomiya, Tohru; Morine, Yuji; Ikemoto, Tetsuya; Mori, Hiroki; Hanaoka, Jun; Iwahashi, Shuichi; Saito, Yu; Miyake, Hidenori // Surgery Today;Jan2012, Vol. 42 Issue 1, p35 

    Purpose: We describe a new technique of ultrasound (US)-guided microwave coagulation (MC) of the Glissonean pedicle, performed before transection to control the inflow and select the resection area. This report introduces our procedure and evaluates the outcomes of patients treated using this...

  • Modeling and analysis of coagulated liver tissue and its interaction with a scalpel blade. Leong, Florence; Huang, Wei-Hsuan; Chui, Chee-Kong // Medical & Biological Engineering & Computing;Jun2013, Vol. 51 Issue 6, p687 

    Radiofrequency-assisted methods have been used in hepatectomy-the resection process of removing liver tissue which encapsulates the tumor from the liver organ. A prototype was built to enable smooth surgical transition between radiofrequency ablation and liver resection. There is a lack of...

  • Hepatectomy for Huge Hepatocellular Carcinoma: Single Institute's Experience. Yang, Lianyue; Xu, Jiangfeng; Ou, Dipeng; Wu, Wei; Zeng, Zhijun // World Journal of Surgery;Sep2013, Vol. 37 Issue 9, p2189 

    Background: The surgical resection of huge hepatocellular carcinoma (HCC) is still controversial. This study was designed to introduce our experience of liver resection for huge HCC and evaluate the safety and outcomes of hepatectomy for huge HCC. Methods: A total of 258 hepatic resections for...

  • Protein Induced by Vitamin K Antagonist-II (PIVKA-II) Is a Reliable Prognostic Factor in Small Hepatocellular Carcinoma. Kim, Jong; Hyuck, Choon; Kwon, David; Joh, Jae-Won; Lee, Joon; Paik, Seung; Park, Cheol // World Journal of Surgery;Jun2013, Vol. 37 Issue 6, p1371 

    Background: Hepatocellular carcinoma (HCC) <2 cm in diameter has a favorable prognosis. Therefore surgical resection of small HCC is associated with good outcomes. However, the predisposing factors of prognosis following resection of HCC remain ill-defined. The aims of the present study were to...

  • HOW I DO IT: Technique of Hepatectomy for Primary Liver Cell Carcinoma in a Developing Country. Irabor, D. O. // East & Central African Journal of Surgery;Apr2013, Vol. 18 Issue 1, p130 

    The experience in managing a 36 year-old Nigerian male with a histopathologically-confirmed hepatocellular carcinoma confined to the left lobe by surgical resection of the liver, using the finger-fracture technique is presented. The literature review on the aetiopathogenesis of this disease and...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics